• Optimizing Pyroptosis Assays with Ac-YVAD-CMK (SKU C4810)

  2026-06-03

  This article addresses common challenges in cell viability and inflammation assays by exploring practical scenarios where Ac-YVAD-CMK (SKU C4810) enhances experimental reproducibility and data clarity. Drawing on recent literature and real-world workflows, it demonstrates why this selective caspase-1 inhibitor is a reliable choice for researchers seeking robust inhibition of IL-1β and IL-18 release.

• O-propargyl-puromycin (OPP) for Real-Time Protein Synthesis

  2026-06-03

  O-propargyl-puromycin (OPP) empowers researchers to quantify nascent protein synthesis with unprecedented precision, even in challenging cellular contexts. Discover workflow enhancements, troubleshooting insights, and the transformative role of OPP in linking mitochondrial function to adaptive immunity.

• VX-745: Precision p38α MAPK Inhibitor for Advanced Inflammat

  2026-06-02

  VX-745 stands out as a highly selective p38α MAPK inhibitor, enabling precise modulation of inflammatory and stress signaling in cellular and animal models. Its dual-action mechanism and robust performance in challenging assays make it an essential tool for researchers pursuing translational breakthroughs in inflammation, oncology, and aging.

• Nelfinavir Mesylate: Benchmark HIV-1 Protease Inhibitor Insi

  2026-06-02

  Nelfinavir Mesylate is a potent HIV-1 protease inhibitor with nanomolar efficacy, strong oral bioavailability, and proven clinical tolerability. It also modulates protein homeostasis and sensitizes cells to ferroptosis via DDI2 inhibition. This dossier provides benchmarks, workflow integration, and clarifies common misconceptions for accurate research application.

• EdU Imaging Kits (488): High-Fidelity S-Phase DNA Synthesis

  2026-06-01

  EdU Imaging Kits (488) deliver rapid, artifact-free cell proliferation analysis using 5-ethynyl-2'-deoxyuridine and click chemistry, eliminating harsh denaturation steps and ensuring superior data integrity. Optimized for both microscopy and flow cytometry, this kit sets a new standard for S-phase measurement in cancer and cell cycle research.

• RNAi Reveals Vesicular Transport Factors in SARS-CoV-2 Relea

  2026-06-01

  Kerr et al. present a comprehensive RNAi screen identifying host vesicular transport factors—particularly Rab11a-mediated pathways—as critical for SARS-CoV-2 release. Their work demonstrates that pharmacological inhibition of CDK9 disrupts viral egress, suggesting new host-targeted antiviral strategies.

• WY-14643 (Pirinixic Acid): Selective PPARα Agonist for Metab

  2026-05-31

  WY-14643 (Pirinixic Acid) is a potent, selective PPARα agonist that modulates lipid metabolism and inflammation. Its efficacy in enhancing insulin sensitivity and reducing inflammatory VCAM-1 expression is supported by both animal and cellular data. The compound’s robust solubility in DMSO and ethanol, but insolubility in water, defines its experimental use.

• ARCA EGFP mRNA for Fluorescence-Based Transfection Control

  2026-05-30

  ARCA EGFP mRNA empowers researchers to directly quantify transfection and gene expression efficiency in mammalian cells, serving as a gold-standard control for optimizing workflow and delivery systems. Its advanced ARCA capping and long poly(A) tail deliver robust fluorescence and high mRNA stability, making it indispensable for both routine and innovative applications.

• Strategic PI3K Activation: 740 Y-P for BMSC and Vesicle Rese

  2026-05-29

  This thought-leadership article explores how 740 Y-P, a potent PI 3-kinase activator, empowers translational researchers to dissect the PI3K/AKT pathway’s role in bone marrow stromal cell (BMSC) survival, vesicular trafficking, and disease modeling. Integrating mechanistic insights and protocol guidance, it bridges recent findings in oxidative stress, autophagy, and regenerative medicine, highlighting how 740 Y-P uniquely supports advanced cell survival and trafficking studies.

• Sisomicin: Mechanism, Benchmarks, and Research Integration

  2026-05-29

  Sisomicin is a broad-spectrum aminoglycoside antibiotic that inhibits bacterial protein synthesis via the 30S ribosomal subunit. Its efficacy spans both Gram-negative and Gram-positive infection models, with well-characterized pharmacokinetics, dosing, and solubility parameters. This article provides evidence-backed integration strategies for researchers investigating bacterial resistance and translational antibacterial workflows.

• SNS-032 (BMS-387032): Data-Driven Solutions for Cancer & Ant

  2026-05-28

  This article explores how SNS-032 (BMS-387032), supplied as SKU A1980, addresses real-world challenges in cell viability, cancer, and host-directed antiviral assays. Scenario-based Q&A blocks provide evidence-based, workflow-ready guidance for researchers optimizing selective cyclin-dependent kinase inhibition, with actionable links to protocols and published data.

• Mitochondrial CAT-Tailing Drives Glioblastoma Growth via RQC

  2026-05-28

  This study uncovers how mitochondrial protein carboxyl-terminal alanine-threonine tailing (msiCAT-tailing), a ribosome-associated quality control (RQC) response, promotes glioblastoma progression by regulating mitochondrial function. The findings identify msiCAT-tailing as a key mechanism linking translational stress to tumor cell survival, suggesting new avenues for therapeutic intervention in aggressive brain cancers.

• Isradipine (Dynacirc) in Neuroprotection & Vascular Research

  2026-05-27

  Isradipine (Dynacirc) stands out as a high-purity, L-type calcium channel blocker for dissecting vascular and neuronal calcium dynamics. Its selective inhibition and robust solubility make it a cornerstone for hypertension and neurodegenerative research, especially in experiments demanding precise control of calcium-mediated excitotoxicity.

• Nigericin Sodium Salt: Applied Workflows for Ion Transport S

  2026-05-27

  Nigericin sodium salt stands out as a robust potassium ionophore, uniquely facilitating rapid and selective K+/H+ exchange across biological membranes for advanced cell assay workflows. This article details practical experimental setups, troubleshooting strategies, and workflow enhancements, connecting the latest in vitro research methods with actionable guidance for translational bench science.

• Moesin as a Biomarker of Endothelial Injury in Sepsis: Insig

  2026-05-26

  This article reviews the 2021 study identifying moesin as a novel biomarker for endothelial injury in sepsis. The findings advance understanding of vascular dysfunction in septic states and provide a foundation for future translational research on endothelial integrity and targeted interventions.

15663 records 1/1045 page Next 12345 下5页 Last page